Meet Our Team
When Steve & Gert joined forces back in 2013, they shared a vision to bring a new level of analytical capability to computational biology and healthcare, building on over 20 years’ experience each in delivering new technologies and products to enable the discovery of richer and more useful links between disease and risk.
Steve is former Global Director of Research Informatics for Astra A/B and is an Advisory Council member for Breast Cancer Now and UKCRC. He specialises in semantic data integration and large scale data analytics for healthcare, and has developed an exceptionally efficient approach to generate comprehensive knowledge graphs of interactions between genes, metabolic pathways, diseases, metabolites and drugs.
Gert is the principal inventor on our patents for the RACE technologies and has won a number of major awards for his innovations.
She specialises in bridging the gap from research to commercialisation and has a substantial international network of industry, commercial & investor contacts. She is a former director of corporate strategy and head of venture strategy at AstraZeneca, where she was responsible for AZ’s global corporate venturing activities, including the creation and $40M financing of the company’s first GI spinout, Albireo.
Serdar is passionate about making a lasting impact on people’s lives by helping understand and manage complex diseases. He has a vast experience base and a deep network of professional connections to help him along the way.
Marcin has hands-on design, development and deployment of multitude of technologies ranging from trading systems, bioinformatics and data science. Following graduation from University of Warsaw, he started his PhD during which he applied AI methods in structural bioinformatics. During his postdoctoral research at Mathematical Medicine, Nationwide Childrens’ Hospital, Columbus, OH, Marcin worked on multiple projects that combined next generation sequencing, statistics, bioinformatics and biomedical research.
Loralyn has held a variety of roles within the life sciences anchored in market development for analytics and ‘omics technologies. She brings a combination of marketing, alliance management, sales and innovation to the company. Her specialty is connecting the dots aligning needs to products to people with a personal mission to help others and upholds the philosophy that better tools = better health.
More about Steve
Steve is a serial technology entrepreneur and occasional angel investor specializing in informatics with a strong track record of building world-class companies, teams and products mainly for the life science industry. He has been directly involved in raising over £50M venture funding for various businesses. Steve has designed, built and brought to market a number of innovative and commercially successful products to support drug discovery and clinical informatics.
Steve has a broad range of technical, senior management, commercial and corporate skills and experience, which I have gained at senior levels in start-up, emerging and Global Fortune 500 companies. He has participated in an London Stock Exchange main market flotation and 11 corporate acquisitions.
Steve has consulted widely for a variety of top 100 life science companies on informatics, business and scientific projects and gained extensive international experience having worked in UK, Europe and the USA. He has published over 30 papers and principal inventor on 24 patents & applications.
- Applications of large scale ontology and semantic technologies (including semantic web) to business problems.
- Semantic integration of structured and unstructured (free text) data.
- Commercialization and marketing strategies for innovative high-tech products and services.
- Translational and stratified medicines research.
- Strong life sciences background specializing in protein structure modelling and computational chemistry, with extensive knowledge of a variety of drug discovery and development technologies.
More about Veronique
Veronique has held a variety of senior international roles in the healthcare industry across several therapeutic areas and functions, including drug development, medical marketing, business development and M&A at AstraZeneca and Grünenthal GmbH. She has also worked in venture capital, as an investment manager with the Rothschild Bioscience Unit in London, and spent five years as a clinician in teaching hospitals in London.
She is a non-executive director of Stevenage Bioscience Catalyst, and Senior Independent Director of International Biotechnology Trust plc. She is a member of the Scientific Committee of Breast Cancer Now, and the Council and Finance and Investment Committee of Queen Mary, University of London. She sits on the advisory board of QMUL School of Business and Management business and the QMUL Life Sciences in Whitechapel initiative.
Veronique holds a medical degree from St Bartholomew’s Hospital Medical School, a BSc in Psychology from University College London and an MBA from INSEAD. She has been awarded the Institute of Directors’ Diploma in Company Direction (Distinction).
More about Gert
Gert is a pioneer in the development of Array Based Logic approaches and systems. His inventions enable the identification of combinations of factors in very complex data spaces that influence an outcome, several orders of magnitude quicker and with higher confidence than existing statistical and machine learning methods.
Gert has applied Array Based technologies at various scales from embedded logic controllers in audio-visual systems, through to projects replacing 1,000 node supercomputers with single GPU devices, e.g. in performing multi-SNP GWAS studies to identify novel clusters of multiple disease associated biomarkers.
He has developed Array Based solutions in the nuclear, railway, electronic product and automotive industries.